Inhibition of miR-320 alleviates hepatic steatosis and dyslipidemia via suppressing the transcription of APOE in MASLD
Yufei Zhou(Huazhong University of Science and Technology), Jianpei Wen(World Wide Web Consortium), Guo Hu(World Wide Web Consortium), K Jin(Tongji Hospital), Feng Wang(Huazhong University of Science and Technology), Junfang Wu(Huazhong University of Science and Technology), Xiang Cheng(Union Hospital), Limin Xia(Tongji Hospital), Xifei He(Tongji Hospital), Hengzhi Du(Tongji Hospital), Huaping Li(Huazhong University of Science and Technology)
Cited by 0
Related Papers
The Cell Type–Specific Functions of miR-21 in Cardiovascular Diseases
|Frontiers in Genetics|2020|74
The role of miR-320 in glucose and lipid metabolism disorder-associated diseases
|International Journal of Biological Sciences|2020|66
The potential effects of DPP‐4 inhibitors on cardiovascular system in COVID‐19 patients
|Journal of Cellular and Molecular Medicine|2020|36
miR-320a induces pancreatic β cells dysfunction in diabetes by inhibiting MafF
|Molecular Therapy — Nucleic Acids|2021|34